01.12.2012 Views

MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME

MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME

MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

227<br />

of 600 participants. Issue 3 of December 2008 states that numbers of recruits had still not reached the target,<br />

so the MRC had granted the Trial team further fund<strong>in</strong>g to allow them to cont<strong>in</strong>ue recruit<strong>in</strong>g until November<br />

2008 to enable them to achieve their target of 600 participants. The PACE Trial Participants’ Newsletter Issue<br />

3 said that because there was a problem with recruit<strong>in</strong>g participants, as well as be<strong>in</strong>g granted more money<br />

by the MRC and more time to achieve the set recruitment levels, it had been decided that an additional Trial<br />

Centre should be opened at Frenchay Hospital, Bristol (which had begun recruit<strong>in</strong>g <strong>in</strong> April 2007).<br />

There was undoubtedly a problem with recruitment and the M<strong>in</strong>utes of the PACE Trial Steer<strong>in</strong>g Committee<br />

held on 22 nd April 2004 record that recruitment estimates “need to be reviewed. It was particularly noted that<br />

it may be worth tra<strong>in</strong><strong>in</strong>g the cl<strong>in</strong>icians who would be recruit<strong>in</strong>g patients <strong>in</strong>to the trial <strong>in</strong> recruitment<br />

strategies and procedures” and that “The protocol will be amended accord<strong>in</strong>gly. These <strong>in</strong>clude: Consider<br />

tra<strong>in</strong><strong>in</strong>g participant recruiters”.<br />

On 12 th May 2004 the Parliamentary Under Secretary of State at the Department of Health, Dr Stephen<br />

Ladyman, announced at an All Party Parliamentary Group on Fibromyalgia (FM) that doctors were be<strong>in</strong>g<br />

offered f<strong>in</strong>ancial <strong>in</strong>ducements to persuade patients with FM to attend a “CFS” Cl<strong>in</strong>ic to aid recruitment to<br />

the PACE Trial. For achievement of the recruitment target to have to depend on f<strong>in</strong>ancial <strong>in</strong>ducements to<br />

cl<strong>in</strong>icians <strong>in</strong> order to persuade patients who do not suffer from <strong>ME</strong>/CFS to enter the PACE Trial would<br />

seem to <strong>in</strong>dicate that someth<strong>in</strong>g is seriously wrong with the trial.<br />

With the aim of improv<strong>in</strong>g “generalisation of our results to a larger number of patients” as well as<br />

improv<strong>in</strong>g recruitment, by letter dated 9 th February 2006 to the West Midland MREC, Peter White<br />

requested changes to the eligibility and primary outcome criteria. He sought permission to change the SF‐<br />

36 threshold for <strong>in</strong>clusion (the <strong>Invest</strong>igators were hav<strong>in</strong>g to turn away patients because they were too well)<br />

and he sought permission to <strong>in</strong>clude patients who had previously received CBT/GET at non‐PACE Trial<br />

centres. What the consequences of allow<strong>in</strong>g an unspecified number of people who had previously<br />

received CBT/GET to jo<strong>in</strong> the PACE Trial might be was not clarified.<br />

By letter dated 14 th July 2006 to the West Midlands MREC, Peter White requested permission to advertise<br />

(his word) the PACE Trial to GPs. The <strong>Invest</strong>igators were really struggl<strong>in</strong>g to recruit participants so decided<br />

to recruit patients direct from primary care. The word<strong>in</strong>g of the advertisement to GPs is <strong>in</strong>terest<strong>in</strong>g: “If you<br />

have a patient with def<strong>in</strong>ite or probable CFS/<strong>ME</strong>, whose ma<strong>in</strong> compla<strong>in</strong>t is fatigue (or a synonym), please consider<br />

referr<strong>in</strong>g them to one of the PACE Trial centres”. Just how scientifically rigorous the <strong>in</strong>clusion of patients<br />

with “fatigue (or a synonym)” might be is a matter for speculation.<br />

Quite certa<strong>in</strong>ly, such broad canvass<strong>in</strong>g has resulted <strong>in</strong> someone who had sh<strong>in</strong>gles (herpes zoster) be<strong>in</strong>g<br />

<strong>in</strong>cluded <strong>in</strong> the PACE Trial on “CFS/<strong>ME</strong>”: s<strong>in</strong>ce the Oxford criteria catch anyone who is chronically<br />

“fatigued”, people with post‐herpetic tiredness are known to be <strong>in</strong>cluded <strong>in</strong> the PACE Trial, even though<br />

herpes zoster is not the same disorder as <strong>ME</strong>/CFS. Such lack of exactitude means that the results of the<br />

PACE Trial could be mean<strong>in</strong>gless.<br />

The PACE Participants’ Newsletter (Issue 2, March 2007) was openly solicit<strong>in</strong>g for more participants: “If you<br />

know of any friends or family who suffer from CFS/<strong>ME</strong> and who might be eligible and <strong>in</strong>terested <strong>in</strong> tak<strong>in</strong>g part <strong>in</strong> the<br />

study and live close enough to one of these centres, please suggest they approach their GP for a referral to a PACE<br />

centre”. The problems with us<strong>in</strong>g exist<strong>in</strong>g participants to recruit new participants are obvious.<br />

First, the exist<strong>in</strong>g participant might no longer feel <strong>in</strong>cl<strong>in</strong>ed to report negative effects and might exaggerate<br />

any positive effects because (i) they may feel they have become part of the PACE research team and thus feel<br />

a loyalty that could <strong>in</strong>fluence how they report their experience and (ii) participants who recruit others are<br />

ask<strong>in</strong>g them to jo<strong>in</strong> <strong>in</strong> their own experience and thus they assume a burden of responsibility, as a result of<br />

which they may be less likely to report ‘it was awful’ or ‘ it did not help’. This could render their own<br />

subjective data <strong>in</strong>valid. Furthermore, if a participant knows s/he has persuaded someone else to jo<strong>in</strong> the

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!